Pursuant to New York Stock Exchange Rule 303A.08, Employee Inducement Awards Are Granted by Teladoc
March 17 2017 - 5:00PM
Business Wire
Teladoc, Inc. (NYSE: TDOC) announced today that it has granted
non-qualified stock options to new employees as material
inducements to their hiring. Stock options for the purchase of a
total of eighty-eight thousand shares of Teladoc’s common stock,
par value $0.001 per share (“Common Stock”), at a price per share
of $22.30 were made to a total of fifteen persons. In addition, in
conjunction with his recent hiring as executive vice president and
chief revenue officer, Mr. Peter N. Nieves received a non-qualified
stock option to purchase four hundred thousand shares of Common
Stock at a price per share of $21.15.
Each of the options awarded vests as to twenty-five percent of
the shares it covers on the first anniversary of its grant, with
the remainder of the shares vesting ratably over thirty-six months
thereafter. All of the options were granted outside the terms of
Teladoc’s 2015 Incentive Award Plan in reliance on the employment
inducement exemption under the NYSE’s Listed Company Manual Rule
303A.08. Pursuant to the requirements of that rule, Teladoc is
issuing this press release.
About Teladoc
Teladoc, Inc. (NYSE:TDOC) is the nation’s leading provider of
telehealth services and a pioneering force in bringing the virtual
care visit into the mainstream of today’s health care ecosystem.
Serving some 7,500 clients — including health plans, health
systems, employers and other organizations — more than 17.5 million
members can use phone, mobile devices and secure online video to
connect within minutes to Teladoc’s network of more than 3,100
board-certified, state-licensed physicians and behavioral health
specialists, 24/7. With national coverage, a robust, scalable
platform and a Lewisville, TX-based member services center staffed
by 400 employees, Teladoc offers the industry’s most comprehensive
and complete telehealth solution including primary care, behavioral
health care, dermatology, tobacco cessation and more. For
additional information, please visit www.teladoc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170317005655/en/
For Teladoc, Inc.Investors:Jisoo Suh,
914-265-6706Director of Investor Relationsjsuh@teladoc.com
Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From Apr 2024 to May 2024
Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From May 2023 to May 2024